Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Boehringer Ingelheim
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01896297
First received: July 8, 2013
Last updated: August 4, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)